Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136965 · ClinicalTrials.gov registry record · Phase 2
Platelet-Rich Plasma Therapy for Patellar Tendinopathy
A Phase 2 study of Patellar Tendinitis, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03136965 is a Phase 2 study of Patellar Tendinitis that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03136965, a Phase 2 study of Patellar Tendinitis, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this research is to find an effective treatment for patellar tendinopathy (PT). To achieve this, we will conduct a double-blinded randomized controlled trial to investigate if platelet-rich plasma is effective for treatment. Clinical (pain and function scores) and bio-mechanical (knee strength) measures will be correlated with disease modification changes assessed using conventional and novel quantitative magnetic resonance imaging (MRI) and ultrasound (US) techniques.
Conditions Studied
Interventions
- PROCEDURE Dry Needling
- BIOLOGICAL PRP
- PROCEDURE Dry Needling - Sham
Study Locations (1)
Wisconsin
- University of Wisconsin, Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2022-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03136965
The ClinicalTrials.gov registry entry for NCT03136965 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patellar Tendinitis appearing as the primary indexed condition, and to 3 interventions - of which Dry Needling is the first listed.
NCT03136965 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03136965 about?
NCT03136965 is a clinical study titled "Platelet-Rich Plasma Therapy for Patellar Tendinopathy". The overall goal of this research is to find an effective treatment for patellar tendinopathy (PT). To achieve this, we will conduct a double-blinded randomized controlled trial to investigate if platelet-rich plasma is effective for treatment. Clinical (pain and function scores) and bio-mechanical ...
What is the current status of trial NCT03136965?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2017-04-25. Estimated completion is 2022-08-15.
What conditions does trial NCT03136965 study?
This clinical trial studies the following conditions: Patellar Tendinitis.
What interventions are being tested in trial NCT03136965?
The interventions under investigation include: Dry Needling (PROCEDURE), PRP (BIOLOGICAL), Dry Needling - Sham (PROCEDURE).
Who is sponsoring clinical trial NCT03136965?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136965 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.